CUBE vs RAPT · P/E 25, rev $1.07B vs $132.1M cap
CubeSmart (CUBE) versus RAPT Therapeutics Inc (RAPT) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
RAPT Therapeutics Inc (RAPT) is a biotechnology company listed on US.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported RAPT revenue for 2023-12-31 was $0. Net income was -$116.8M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. RAPT currently screens at market cap $132.1M.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. RAPT currently screens at market cap $132.1M.
Not investment advice. Open the CUBE and RAPT stock pages for the full models.
Not investment advice.